InvestorsObserver
×
News Home

Does GT Biopharma Inc (GTBP) Have What it Takes to be in Your Portfolio Monday?

Monday, October 04, 2021 10:54 AM | InvestorsObserver Analysts

Mentioned in this article

Does GT Biopharma Inc (GTBP) Have What it Takes to be in Your Portfolio Monday?

The 49 rating InvestorsObserver gives to GT Biopharma Inc (GTBP) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 71 percent of stocks in the Biotechnology industry, GTBP’s 49 overall rating means the stock scores better than 49 percent of all stocks.

Overall Score - 49
GTBP has an Overall Score of 49. Find out what this means to you and get the rest of the rankings on GTBP!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 49 means the stock is more attractive than 49 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes

InvestorsObserver

’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With GT Biopharma Inc Stock Today?

GT Biopharma Inc (GTBP) stock is trading at $6.26 as of 10:49 AM on Monday, Oct 4, a loss of -$0.36, or -5.51% from the previous closing price of $6.62. The stock has traded between $6.15 and $6.49 so far today. Volume today is less active than usual. So far 63,257 shares have traded compared to average volume of 384,841 shares. Click Here to get the full Stock Report for GT Biopharma Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App